Related Experiment Videos
Age-related digoxin effects in an intact canine model
This study compared how the heart drug digoxin affects cardiovascular function in newborn versus adult dogs. Researchers found that while the drug significantly improved heart muscle contraction in adults, its effects were much weaker or absent in newborns. These findings suggest that age-related differences in heart physiology significantly alter how the body responds to this common medication.
Area of Science:
- Pediatric cardiology and digoxin pharmacodynamics
- Veterinary physiology and cardiovascular research
Background:
Prior research has not fully clarified how cardiac responses to specific medications change during early development. It was already known that developmental maturation influences cardiovascular sensitivity to various pharmacological agents. That uncertainty drove the investigation into whether young subjects exhibit the same physiological reactions as mature counterparts. Scientists previously lacked comprehensive data comparing these distinct age groups under controlled experimental conditions. This gap motivated the current assessment of heart function following drug administration in a canine model. The study addresses whether neonatal hearts react to therapeutic interventions with similar intensity to adult hearts. Understanding these variations remains a challenge for clinicians managing pediatric patients. No prior work had resolved the specific differences in electromechanical timing between these two developmental stages.
Purpose Of The Study:
The aim of this investigation was to determine if digoxin exerts comparable cardiac effects in neonatal versus adult canine models. Researchers sought to test the hypothesis that developmental maturity does not alter the drug's impact on heart function. The study addressed the potential for age-related variations in myocardial sensitivity to pharmacological stimulation. By comparing these two distinct groups, the team intended to clarify whether pediatric patients respond to the medication with the same intensity as adults. This work was motivated by the need to understand how physiological maturation influences therapeutic outcomes. The investigators examined several hemodynamic and electrophysiologic parameters to quantify these potential differences. They specifically focused on timing intervals that reflect the mechanical efficiency of the heart muscle. No prior work had systematically compared these responses in an intact model to establish clear developmental benchmarks.
Main Methods:
Review Approach involved anesthetized canine subjects categorized into neonatal and adult cohorts to evaluate drug responsiveness. The investigators administered a fixed dose of 50 micrograms per kilogram intravenously to all animals. Researchers performed continuous monitoring of electrocardiograms and central arterial pressure to gather essential hemodynamic data. The team calculated the systolic time interval by dividing the preejection period by the ejection time. They also determined the total electromechanical systole by summing these two specific timing components. This value was further adjusted to account for variations in the heart rate. A two-way analysis of variance served as the primary statistical method to compare the responses between the two age groups. Pharmacokinetic assessments confirmed that the drug reached a stable equilibrium state before the collection of physiological measurements.
Main Results:
Key Findings From the Literature show that the drug produced significantly different effects on heart rate and systolic function between the two groups. In adult animals, the heart rate dropped from 116 to 66 beats per minute. The systolic time interval in adults decreased from 0.559 to 0.447. Indexed total electromechanical systole in adults fell from 333 to 291 milliseconds. Conversely, neonatal subjects showed no significant changes in heart rate or systolic time intervals compared to control animals. The only notable change in neonates was a reduction in indexed total electromechanical systole from 288 to 270 milliseconds. Statistical testing confirmed that the drug influenced heart rate and systolic indices differently in neonates versus adults. These results highlight a clear disparity in how the heart responds to this medication based on developmental age.
Conclusions:
The authors propose that age-related physiological maturation dictates the magnitude of cardiac responses to this specific drug. Synthesis and Implications reveal that neonatal subjects show a markedly blunted reaction compared to mature animals. These data indicate that standard dosing guidelines might require adjustment when treating younger populations. The researchers suggest that developmental differences in myocardial sensitivity play a major role in these observed discrepancies. Their findings highlight that the drug does not produce uniform effects across different stages of life. The study provides evidence that neonatal hearts possess distinct electromechanical properties compared to adults. These results imply that clinicians should exercise caution when extrapolating adult pharmacological data to pediatric cases. Future clinical practice may benefit from recognizing these age-dependent variations in drug efficacy.
Frequently Asked Questions
The researchers propose that digoxin significantly reduces heart rate and improves systolic function in adults, whereas neonates show minimal changes. This demonstrates that age-related maturation alters the drug's impact on cardiac performance, with adults exhibiting a more pronounced response than the younger group.
The study utilized electrocardiograms and central arterial pressure monitors to track changes. These tools allowed the team to calculate the systolic time interval and total electromechanical systole, providing a precise assessment of how the heart muscle contracts following drug delivery.
The researchers measured parameters starting at 5.75 hours after injection. This timing was necessary to ensure the drug had reached a rapid distribution phase and achieved equilibrium conditions, allowing for accurate physiological readings that reflect stable drug concentrations in the bloodstream.
The team employed systolic time intervals and total electromechanical systole as key metrics. These indices served as indicators of systolic function, helping the investigators quantify the mechanical efficiency of the heart muscle in response to the administered medication.
The investigators observed a significant decrease in indexed total electromechanical systole in neonates, dropping from 288 to 270 milliseconds. In contrast, adults experienced a much larger reduction, falling from 333 to 291 milliseconds, highlighting the disparity in drug responsiveness between the groups.
The authors propose that these findings indicate that developmental maturity is a primary factor in drug sensitivity. They suggest that clinicians must account for these age-dependent differences to avoid potential therapeutic errors when applying adult-derived pharmacological knowledge to neonatal patients.